期刊文献+

液相色谱-电喷雾电离质谱法检测地高辛人血浆药物浓度方法学的建立与考证 被引量:1

Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the determination of digoxin in human plasma
下载PDF
导出
摘要 目的:建立适用于地高辛临床血药浓度监测的液相色谱-电喷雾电离质谱方法(LC-ESI-MS)。方法:地高辛人血浆样本采用乙酸乙酯液液萃取后以LC-ESI-MS方法进行分析。采用Kro-masilC18柱(150mm×2.00mm,3.5μm)分析柱;在乙腈和氯化铵的混合流动相的流动相系统中,进行梯度洗脱,选择性负离子检测,地高辛m/z为815.40,内标Rg2m/z为819.00。结果:地高辛在0.05~10.0ng/mL浓度范围内线性关系良好(r=0.9989),血浆内杂质不影响药物的检测,方法回收率大于75%,批内、批间变异均小于15%,冻融稳定性良好。结论:本研究所建立的LC-ESI-MS测定方法操作简便、快速、灵敏,准确,重现性好,所需血浆量少,可用于地高辛临床血药浓度监测及临床药动学研究。 AIM:To develop a sensitive and selective liquid chromatography-electrospray ionization mass spectrometry(LC-ESI-MS)method for clinical identification and quantification of digoxin in human plasma.METHODS:The method was based on simple liquid-liquid extraction(LLE).A Kromasil C18 column(150 mm×2.00 mm,3.5 μm)was used as the analytical column,while a mixture of acetonitrile and 500 μmol/L ammonium chloride was used as the mobile phase.MS detection was performed using a single quadrupole mass spectrometer in a...
出处 《中国临床药理学与治疗学》 CAS CSCD 2008年第12期1422-1425,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 地高辛 液相色谱-电喷雾电离质谱法 血药浓度监测 digoxin liquid chromatographic/electrospray ionization mass spectrometric method therapeutic drug monitoring
  • 相关文献

参考文献8

  • 1Sechaud R,Robeva A,Belleli R,et al.Absence of an effect of a single-dose deferasirox onthe steady-state phar-macokinetics of digoxin[].International Journal of Clinical Pharmacology Research.2008
  • 2Tzou MC,Sams RA,Reuning RH.Specific and sensitive determination of digoxin and metabolites in human serum by high performance liquid chromatography with cyclodex-trin solid-phase extraction and precolumn fluorescence de-rivatization[].Journal of Pharmaceutical and Biomedical Analysis.1995
  • 3Packer,M,Gheorghiade,M,Young,JB,Costantini,PJ,Adams,KF,Cody,RJ,Smith,LK,van,Voorhees,L,Gourley,LA,Jolly,MK.Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors[].The New England Journal of Medicine.1993
  • 4Uretsky BF,Young JB,Shahidi FE,et al.Randomized study assessing the effect of di goxin withdrawal in patients with mild to moderate chronic congestive heart failure[].Journal of the American College of Cardiology.1993
  • 5The Digitalis Investigation Group.The effect of digoxin on mortalityand morbidity in patients with heart failure[].The New England Journal of Medicine.1997
  • 6Ahmed A,Rich MW,Fleg JL,et al.Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial[].Circulation.2006
  • 7Kerstin A. Graefe,Zhe Tang and H. Thomas Karnes.High-performance liquid chromatography with on-line post-column immunoreaction detection of digoxin and its metabolites based on fluorescence energy transfer in the far-red spectral region[].Journal of Chromatography B: Biomedical Sciences and Applications.2000
  • 8Tracqui,A,Kintz,P,Ludes,B,Mangin,P.High-performance liquid chromatography–ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma[].Journal of Chromatography B.1997

同被引文献24

  • 1李红,张恒.地高辛临床应用过程中血药浓度的监测[J].齐鲁医学杂志,2006,21(2):162-162. 被引量:4
  • 2Gheorghiade M, Harinstein ME,Filippatos GS. Digoxin for the treatment of chronic and acute heart failure syndromes [J]. Acute Card Care, 2009,11 (2) : 83-87.
  • 3Xu R, Lin G, Wang W,etal. Application of an ELISA-elution Assay to Dissociate Digoxin antibody Complexes in Immunoaf- finity Chromatography[J]. Scandinavian J Immunol, 2010,71 : 55-60.
  • 4Kirby BJ, Kalhorn T, Hebert M,et al. Sensitive and specific LC-MS assay for quantification of digoxin in human plasma and urine[J]. Biomed Chromatogr, 2008,22 (7) : 712-718.
  • 5Kiousi P, Angelis YS, Koupparis M,et al. Gas chromatograph- ic-mass spectrometric cardiotonic glycosides detection in equine urine doping analysis[J]. Chromatographia Supplement, 2004, 59:105-108.
  • 6Schultz RA,Kellerman TS, van den Berg H. The role of fluo- rescence polarization immunoassay in the diagnosis of plant-in- duced cardiac glycoside poisoning livestock in South Africa[J]. Onderstepoort J Vet Res, 2005,72 (3) : 189-201.
  • 7Dasgupta A. The new enzyme-linked immunosorbent digoxin assay on the ADVIA integrated modular system(R) is virtually free from oleander interference[J]. Therapeutic Drug Monito ring,2006,28 (2) :282-285.
  • 8Dasgupta A, Reyes MA. Ginseng and Digoxin Assays: Discus- sion[J]. Am J Clin Pathol,2005,124(2) :229-236.
  • 9Dasgupta A, Kang E, Datta P. A new enzyme-linked chemilumi- nescent immunosorbent digoxin assay is virtually free from in- terference of spironolactone, potassium canrenoate, and their common metabolite canrenone[J]. J Clin Laborat Analysis,2006,20(5):204-208.
  • 10Yamada T, Suzuki K, Iguchi K, et al. Interference between eplerenone and digoxin in fluorescence polarization irnmunoas- say, micropartiele enzyme imrnunoassay, and affinity column- mediated immunoassay[ J ]. Ther Drug Monit, 2010, 32 (6) : 774-777.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部